சுற்றோட்ட அமைப்பு சாதனங்கள் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சுற்றோட்ட அமைப்பு சாதனங்கள் குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சுற்றோட்ட அமைப்பு சாதனங்கள் குழு Today - Breaking & Trending Today

Donor Heart Preserver Survives Review by FDA Advisors


email article
The TransMedics Organ Care System (OCS) Heart System got closer to regulatory approval as it emerged victorious from a contentious FDA advisory committee meeting.
Members of the agency s Circulatory System Devices Panel voted 12-5 (with one abstention) that the OCS Heart System s benefits outweigh its risks as a device that could potentially widen the pool of donor hearts perhaps even reduce waitlist times by preserving non-standard donor hearts longer than traditional cold storage during transport.
Panelists voting in favor did so despite complaining of flimsy safety and effectiveness data in the PROCEED II, EXPAND, and EXPAND CAP studies. ....

United States , Keith Allen , Nicole Lou , Murray Kwon , Jason Connor , Waleed Hassanein , George Vetrovec , Joaquin Cigarroa , School Of Medicine , Oregon Health Science University In Portland , Health Pauley Heart Center , Circulatory System Devices Panel , Transmedics Organ Care System , Heart System , Pauley Heart Center , Kansas City , Oregon Health , Science University , Medpage Today , ஒன்றுபட்டது மாநிலங்களில் , மிச Ou ரி , கேய்ட் ஆலன் , நிக்கோல் லூ , முர்ரே க்குவொன் , ஜேசன் இணைப்பான் , வாலீட் ஹஸ்ஸனேன் ,

TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System


TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System
News provided by
Share this article
Share this article
ANDOVER, Mass., April 6, 2021 /PRNewswire/  TransMedics Group, Inc. ( TransMedics ) (NASDAQ: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that Nasdaq has halted trading of the company s common stock.
The U.S. Food and Drug Administration s (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee is meeting today to review TransMedics Organ Care System™ (OCS) Heart System. The OCS™ Heart System is a portable organ perfusion and monitoring medical device intended to preserve a donated heart in a near-physiologic, beating and perfused state, while continually monitoring and optimizing heart function for eventual transplantation into the reci ....

United States , Transmedics Inc , Transmedics Group Inc , Drug Administration , Advisory Committee , Transmedics Group , Circulatory System Devices Panel , Medical Devices Advisory Committee , Transmedic Organ Care System , Heart System , Annual Report , ஒன்றுபட்டது மாநிலங்களில் , சுற்றோட்ட அமைப்பு சாதனங்கள் குழு , இதயம் அமைப்பு , ஆண்டு அறிக்கை ,